Indications
- treatment of neuropathic pain in adults (18 years and older). Efficacy and safety in patients under 18 years of age have not been established;
- monotherapy of partial seizures in epilepsy with and without secondary generalization in adults and children over 12 years of age. The efficacy and safety of monotherapy in children under 12 years of age have not been established;
- as an adjunct in the treatment of partial seizures in epilepsy with and without secondary generalization in adults and children aged 3 years and older. The safety and efficacy of gabapentin supplemental therapy in children less than 3 years of age have not been established.
Reviews
There are no reviews yet